The simple urine test correctly identified bladder cancer-associated genes in 71 of 77 patients who went on to develop a ...
AUSTIN, Texas - Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, announced that its Signatera test has received regulatory approval from Japan's Pharmaceuticals ...
A non-invasive urine test could speed up diagnosis of bladder cancer, an NHS study has found. Trials of the GALEAS urine bladder test across seven NHS sites found it discovered nine in ten patients ...
Even one pink or rusty toilet-bowl visit warrants a same-day call to your doctor.
Veracyte has acquired Convergent Genomics in a transaction valued at up to $180 million, adding the UroAmp urinary tumor DNA ...
For appropriately selected patients with muscle-invasive bladder cancer, preserving the bladder can be a curative treatment ...
A new study published in Nature has established the foundational landscape of tumor evolution in bladder cancer and ...
The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...
Trimodal therapy can be an alternative to radical cystectomy for select patients with cT2-4aN0M0 muscle-invasive bladder cancer.
Remission rates observed in a Phase 2 trial fell short of Wall Street's expectations, though some analysts believe the ...
A new study has found that the use of a specific at-home urine test could detect bladder cancer with accuracy. Here are its implications and why this test is a medical breakthrough.
A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care. The research, ...